Viibryd and Amerge drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viibryd (vilazodone hydrochloride) and Amerge (naratriptan hydrochloride). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Viibryd and Amerge. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

What is Amerge?

Amerge has active ingredients of naratriptan hydrochloride. It is often used in migraine. eHealthMe is studying from 1,470 Amerge users. Check the latest studies of Amerge.

On Jul, 20, 2026

11 people who take Viibryd and Amerge together, and have interactions are studied.

What are the common drug interactions of Viibryd and Amerge, by gender? *:

female:

Drug ineffective
Alopecia (absence of hair from areas of the body)
Confusional state
Decreased appetite
Drug effect increased
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Headache (pain in head)
Hypokalaemia (low potassium)
Hypoxia (low oxygen in tissues)

male:

n/a

What are the common drug interactions of Viibryd and Amerge, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Alopecia (absence of hair from areas of the body)
Drug ineffective
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscle tightness
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Fatigue (feeling of tiredness)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Sensory loss (senses loss)
Visual impairment

40-49:

n/a

50-59:

Acute respiratory failure
Chronic respiratory failure
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Rehabilitation therapy
Respiratory distress (difficulty in breathing)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
Confusional state

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 72.73%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 27.27%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 18.18%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 9.09%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 9.09%
Asthma: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Viibryd and Amerge?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously